Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-09-02FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Atenolol from Aurobindo Pharma Limited, confirming approval of a generic Atenolol product under …
-
FDA approval · 2009-08-31FDA Approved: HEPARIN SODIUM — Original Application (Hospira, Inc.)
FDA approved an original ANDA for heparin sodium, enabling its generic commercialization by Hospira, Inc.
-
FDA approval · 2009-07-23FDA Approved: HEPARIN SODIUM AND DEXTROSE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Heparin Sodium and Dextrose (Heparin Sodium) from Hospira, Inc. The approval updates the product…
-
FDA approval · 2009-05-29FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for lisinopril from Quallent Pharmaceuticals Health LLC, enabling continued access to lisinopril…
-
FDA approval · 2009-04-29FDA Approved: TECHNETIUM TC 99M SESTAMIBI — Original Application (Jubilant Draximage (USA) Inc.)
FDA approved Jubilant Draximage (USA) Inc.'s original ANDA for Technetium Tc-99m Sestamibi, a radiopharmaceutical used in myocardial perfusi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-02-26FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate from Aurobindo Pharma Limited, confirming regulatory clearance for the gener…
-
FDA approval · 2009-02-19FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Atenolol filed by Zydus Lifesciences Limited, resulting in approval of a generic Atenolol produc…
-
FDA approval · 2008-11-04FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for metoprolol tartrate by Hospira, Inc., indicating regulatory action on this generic product. The …
-
FDA approval · 2008-10-21FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Metoprolol Tartrate from Mylan Pharmaceuticals Inc., authorizing a generic version to be mar…
-
FDA approval · 2008-09-30FDA Approved: CARVEDILOL — Supplemental Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved a supplemental application for carvedilol from Unichem Pharmaceuticals (USA), Inc., expanding labeling for this product.
-
FDA approval · 2008-08-29FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Atenolol from Zydus Lifesciences Limited under the ANDA.
-
FDA approval · 2008-08-22FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))
FDA approved a supplemental application for lisinopril from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. to market a generi…
-
FDA approval · 2008-07-24FDA Approved: LOPRESSOR — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for Lopressor (metoprolol tartrate) from Validus Pharmaceuticals LLC.
-
FDA approval · 2008-06-20FDA Approved: RAMIPRIL — Original Application (GSMS, Incorporated)
FDA approved RAMIPRIL as a generic drug under an original Abbreviated New Drug Application (ANDA 079116) filed by GSMS, Incorporated.
-
FDA approval · 2008-06-18FDA Approved: RAMIPRIL — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original ANDA for ramipril, authorizing the marketing of a generic ramipril product.
-
FDA approval · 2008-06-18FDA Approved: RAMIPRIL — Original Application (Chartwell RX, LLC.)
The FDA approved Chartwell RX, LLC's original generic application for ramipril, enabling the marketing of a RAMIPRIL product.
-
FDA approval · 2008-05-13FDA Approved: TNKASE — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for TNKASE (tenecteplase) filed by Genentech, Inc., enabling changes to the product's labeling a…
-
FDA approval · 2008-04-29FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
FDA approved a supplemental application for TENORMIN (atenolol) submitted by Almatica Pharma LLC.
-
FDA approval · 2008-04-23FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for enalapril maleate (a generic ACE inhibitor) by Heritage Pharmaceuticals (d/b/a Avet Pharmace…
-
FDA approval · 2008-01-28FDA Approved: LISINOPRIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for lisinopril from Aurobindo Pharma Limited.
-
FDA approval · 2008-01-14FDA Approved: CLOPIDOGREL BISULFATE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's clopidogrel bisulfate tablet under an Original Application (ANDA076273). The approval enable…
-
FDA approval · 2008-01-08FDA Approved: LOPRESSOR — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for Lopressor (metoprolol tartrate) filed by Validus Pharmaceuticals LLC.
-
FDA approval · 2007-11-13FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for CAPTOPRIL (captopril), approving an additional change to the approved ANDA…
-
FDA approval · 2007-10-31FDA Approved: ATENOLOL — Original Application (Aurobindo Pharma Limited)
FDA approved Atenolol from Aurobindo Pharma Limited under an Original Application (ANDA) for a generic beta-blocker.
-
FDA approval · 2007-10-23FDA Approved: QUINAPRIL — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Quinapril submitted by BluePoint Laboratories. This approval updates the existing Quinapril …